One-Year Outcome of Cardiac Contractility Modulation in Patients With Reduced Ejection Fraction, Atrial Fibrillation, and Previous Resynchronization: A Pilot Study

医学 射血分数 心脏病学 心力衰竭 内科学 心房颤动 心脏再同步化治疗 收缩性 糖尿病 内分泌学
作者
Diana Țînț,Sorin Micu
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:30 (1): e10-e16 被引量:1
标识
DOI:10.1097/mjt.0000000000001579
摘要

After 6 months of therapy, cardiac contractility modulation (CCM) has been shown to improve symptoms, exercise tolerance, and quality of life as well as reduce the rate of hospitalizations in patients with heart failure with reduced left ventricular ejection fraction (HFrEF), but long-term effects data are lacking, with no randomized trial to date.What is the long-term benefit of the CCM device implantation in symptomatic patients with severe, optimally treated HFrEF?We conducted a prospective trial involving patients with symptomatic HFrEF [New York Heart Association (NYHA) Class III or IV, left ventricular ejection fraction (LVEF) ≤35%] who were supported by a CCM device.Twenty patients (19 men), aged 66.5 ± 6.9 years, were provided with CCM therapy and followed up for an average duration of 321.7 ± 113.5 days. The etiology of heart failure was ischemic in 16 patients (80%), 9 patients (45%) had atrial fibrillation, 6 patients (30%) had diabetes mellitus, and mean creatinine clearance value was 54.8 ± 13.0 mL/min. Eleven patients (60%) had LVEF ≤25%. Although all the patients had an implanted cardioverter-defibrillator, 6 of them (30%) also had resynchronization therapy. The pharmacological treatment has been optimized in all patients. One year after implantation, the LVEF increased from 24.68% ± 4.5 to 34.6 ± 5 ( P < 0.0001), NYHA class improved from 3.2 ± 0.5 to 1.4 ± 0.5 ( P < 0.0001), and exercise tolerance evaluated with a 6-Minute Walk Test increased (from 307.9 ± 74.1 m to 567 ± 99.5 m; P < 0.00001). These improvements were largely seen in the first 6 months.Over the course of a year, CCM therapy was associated with improved LVEF and NYHA class, as well as significantly better exercise tolerance, even in patients with atrial fibrillation and cardiac resynchronization therapy and did not seem to be associated with additional significant device-related problems.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
饲养员完成签到,获得积分10
1秒前
cc发布了新的文献求助10
1秒前
雪白的雪完成签到,获得积分10
1秒前
1秒前
李佳静完成签到,获得积分10
1秒前
1秒前
知性的惜芹完成签到 ,获得积分10
2秒前
陆哈哈发布了新的文献求助10
2秒前
2秒前
拼搏向上发布了新的文献求助10
2秒前
务实赛凤发布了新的文献求助10
5秒前
爱笠发布了新的文献求助10
5秒前
白山茶完成签到,获得积分10
5秒前
5秒前
香蕉觅云应助哈哈哈哈采纳,获得10
5秒前
xinjiasuki完成签到 ,获得积分10
6秒前
6秒前
隐形曼青应助ljymedical采纳,获得10
6秒前
英勇白莲发布了新的文献求助10
6秒前
leooooo发布了新的文献求助10
6秒前
7秒前
小二郎应助oguricap采纳,获得10
7秒前
柱子大王赵磊磊完成签到,获得积分10
7秒前
7秒前
zjcc完成签到 ,获得积分20
7秒前
杰克开膛手完成签到,获得积分10
8秒前
8秒前
山茶完成签到,获得积分10
8秒前
Sponge妞完成签到 ,获得积分10
8秒前
Jasper应助pegtop采纳,获得10
9秒前
坦率岱周完成签到,获得积分10
9秒前
裴道天完成签到 ,获得积分10
9秒前
平常莆发布了新的文献求助10
9秒前
呆萌若云关注了科研通微信公众号
9秒前
bioinfo_sc发布了新的文献求助10
9秒前
雪白的芝关注了科研通微信公众号
9秒前
柒姐完成签到,获得积分10
10秒前
CC完成签到,获得积分10
10秒前
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Research Methods for Applied Linguistics 500
Picture Books with Same-sex Parented Families Unintentional Censorship 444
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6414769
求助须知:如何正确求助?哪些是违规求助? 8233772
关于积分的说明 17483304
捐赠科研通 5467675
什么是DOI,文献DOI怎么找? 2888828
邀请新用户注册赠送积分活动 1865772
关于科研通互助平台的介绍 1703420